Circassia Pharmaceuticals Plc Block Listing Application (6051G)
May 31 2017 - 1:00AM
UK Regulatory
TIDMCIR
RNS Number : 6051G
Circassia Pharmaceuticals Plc
31 May 2017
31 May 2017
Circassia Pharmaceuticals plc
Block Listing Application
Circassia Pharmaceuticals plc ("Circassia" or "the Company")
today announces that an application (the "Application") has been
made to the UK Listing Authority and the London Stock Exchange for
a block listing of 1,016,000 ordinary shares of 0.08 pence each in
the Company ("Ordinary Shares") to be admitted to trading on the
Premium Segment of the London Stock Exchange.
The Application relates to Ordinary Shares to be issued from
time to time in order to satisfy the potential exercise of share
options granted under employee share schemes:
2007 Unapproved Share Scheme: 516,000 Ordinary Shares
2014 Performance Share Plan Scheme: 500,000 Ordinary Shares
It is expected that admission will become effective on 1 June
2017. When issued, the Ordinary Shares will rank pari passu with
the existing ordinary shares of the Company.
As at today, there are 332,244,588 ordinary shares in issue with
one voting right per share. The Company does not hold any shares in
treasury. The Company will notify on a monthly basis when there are
changes to the issued share capital of the Company, and these
monthly figures may be used by shareholders as the denominator for
the calculation by which they will determine if they are required
to notify their interest in, or a change in their interest in, the
share capital of the Company under the FCA's Disclosure Guidance
and Transparency Rules.
-Ends-
For further information, please contact:
Circassia Pharmaceuticals plc
Julien Cotta, Company Secretary Tel: +44 (0) 1865 405 560
This information is provided by RNS
The company news service from the London Stock Exchange
END
ALSEBLFXDEFFBBZ
(END) Dow Jones Newswires
May 31, 2017 02:00 ET (06:00 GMT)
Circassia (LSE:CIR)
Historical Stock Chart
From Apr 2024 to May 2024
Circassia (LSE:CIR)
Historical Stock Chart
From May 2023 to May 2024